These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30045248)

  • 1. Treatment responses to antiangiogenetic therapy and chemotherapy in nonsecreting paraganglioma (PGL4) of urinary bladder with SDHB mutation: A case report.
    Stigliano A; Lardo P; Cerquetti L; Aschelter AM; Matarazzo I; Capriotti G; Schiavi F; Marchetti P; Nardone MR; Petrangeli E; Toscano V
    Medicine (Baltimore); 2018 Jul; 97(30):e10904. PubMed ID: 30045248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sunitinib in the therapy of malignant paragangliomas: report on the efficacy in a SDHB mutation carrier and review of the literature.
    Canu L; Pradella S; Rapizzi E; Fucci R; Valeri A; Briganti V; Giachè V; Parenti G; Ercolino T; Mannelli M
    Arch Endocrinol Metab; 2017; 61(1):90-97. PubMed ID: 27737332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
    Hadoux J; Favier J; Scoazec JY; Leboulleux S; Al Ghuzlan A; Caramella C; Déandreis D; Borget I; Loriot C; Chougnet C; Letouzé E; Young J; Amar L; Bertherat J; Libé R; Dumont F; Deschamps F; Schlumberger M; Gimenez-Roqueplo AP; Baudin E
    Int J Cancer; 2014 Dec; 135(11):2711-20. PubMed ID: 24752622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: A novel somatic
    Nguyen T; Ordulu Z; Shrestha S; Patel U; Crispen PL; Brown L; Falzarano SM; Ghayee HK; Perdomo Rodriguez JP
    Front Endocrinol (Lausanne); 2024; 15():1386285. PubMed ID: 38911036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.
    Majumdar S; Friedrich CA; Koch CA; Megason GC; Fratkin JD; Moll GW
    Pediatr Blood Cancer; 2010 Mar; 54(3):473-5. PubMed ID: 19927285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic Characteristics and Mutational Status of Succinate Dehydrogenase Genes in Paraganglioma of the Urinary Bladder: A Multi-Institutional Korean Study.
    Park S; Kang SY; Kwon GY; Kwon JE; Kim SK; Kim JY; Kim CH; Kim HJ; Moon KC; Pyo JY; Park WY; Park ES; Sung JY; Sung SH; Oh YH; Lee SE; Lee W; Lee JI; Cho NH; Jung SJ; Cho MS; Cho YM; Cho HY; Cha EJ; Chae YS; Choe G; Choi YJ; Huh J; Ro JY
    Arch Pathol Lab Med; 2017 May; 141(5):671-677. PubMed ID: 27819762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
    Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
    Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127).
    Gupta S; Zhang J; Milosevic D; Mills JR; Grebe SK; Smith SC; Erickson LA
    Endocr Pathol; 2017 Sep; 28(3):253-268. PubMed ID: 28646318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene.
    Timmers HJ; Pacak K; Huynh TT; Abu-Asab M; Tsokos M; Merino MJ; Baysal BE; Adams KT; Eisenhofer G
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4826-32. PubMed ID: 18840642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant bladder pheochromocytoma with SDHB genetic mutation.
    Maeda M; Funahashi Y; Katoh M; Fujita T; Tsuruta K; Gotoh M
    Aktuelle Urol; 2013 Sep; 44(5):381-2. PubMed ID: 23807799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
    Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
    JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel SDHB and TMEM127 Mutations in Patients with Pheochromocytoma/Paraganglioma Syndrome.
    Patócs A; Lendvai NK; Butz H; Liko I; Sapi Z; Szucs N; Toth G; Grolmusz VK; Igaz P; Toth M; Rácz K
    Pathol Oncol Res; 2016 Oct; 22(4):673-9. PubMed ID: 26960314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continued Tumor Reduction of Metastatic Pheochromocytoma/Paraganglioma Harboring Succinate Dehydrogenase Subunit B Mutations with Cyclical Chemotherapy.
    Jawed I; Velarde M; Därr R; Wolf KI; Adams K; Venkatesan AM; Balasubramaniam S; Poruchynsky MS; Reynolds JC; Pacak K; Fojo T
    Cell Mol Neurobiol; 2018 Jul; 38(5):1099-1106. PubMed ID: 29623478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations.
    Jochmanova I; Wolf KI; King KS; Nambuba J; Wesley R; Martucci V; Raygada M; Adams KT; Prodanov T; Fojo AT; Lazurova I; Pacak K
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1421-1435. PubMed ID: 28374168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
    Chen H; Yao W; He Q; Yu X; Bian B
    BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
    Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel succinate dehydrogenase subunit B germline variant associated with head and neck paraganglioma in a Dutch kindred: A family-based study.
    de Vos B; Rijken JA; Adank MA; Hoksbergen AWJ; Bayley JP; Leemans CR; Hensen EF
    Clin Otolaryngol; 2018 Jun; 43(3):841-845. PubMed ID: 29292578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
    Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
    Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
    Barbolosi D; Crona J; Serre R; Pacak K; Taieb D
    PLoS One; 2018; 13(8):e0201303. PubMed ID: 30106970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.